Evidence map›Paper›PMID 39985042›Full record

ArticleJournal of experimental & clinical cancer research : CR2025

The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts.

Ilenia Masi, Flavia Ottavi, Valentina Caprara, Danila Del Rio, Martina Kunkl, Francesca Spadaro, Valerio Licursi, Loretta Tuosto, Anna Bagnato, Laura Rosano'

Abstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ilenia Masi *Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Flavia Ottavi *Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Valentina CapraraUnit of Preclinical Models and New Therapeutic Agents, IRCCS, Regina Elena National Cancer Institute, Rome, Italy.
Danila Del RioInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Martina KunklDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University, Rome, Italy.
Francesca SpadaroConfocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
Valerio LicursiInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
Loretta TuostoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University, Rome, Italy.
Anna BagnatoUnit of Preclinical Models and New Therapeutic Agents, IRCCS, Regina Elena National Cancer Institute, Rome, Italy.
Laura Rosano'Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy. laura.rosano@cnr.it.ORCID http://orcid.org/0000-0002-9962-6411

Funding

Fondazione AIRC per la ricerca sul cancro ETS 21372Ministero dell'Istruzione, dell'Università e della Ricerca P2022Z7TEC
6 · The paper itself

Abstract

backgroundThe invasive and metastatic spread of serous ovarian cancer (SOC) results from the cooperative interactions between cancer and stroma, which include extracellular matrix (ECM) and cellular components, including cancer-associated fibroblasts (CAFs). Soluble factors secreted by cancer and stromal cells contribute to stroma remodeling through the secretion of ECM proteins, providing a favorable environment for cancer cell dissemination. The peptide endothelin-1 (ET-1), through two G protein-coupled receptors (GPCR), endothelin receptor type A (ET

methodsWe used human primary ovarian fibroblasts (HOFs) and CAFs. The expression of Col1 (COL1A1) and FN (FN1) were detected by western blotting (WB), quantitative real time-polymerase chain reaction (qRT-PCR), immunofluorescence (IF), and confocal laser scanning microscopy (CLSM) in cells and tumor tissue sections from mice xenografts, while the transcription of COL1A1 was detected by luciferase reporter gene assay. The nuclear function of β-arr1 was evaluated by silencing and rescue expression with wild-type (WT) and nuclear mutant plasmid constructs, RNA seq and differential gene expression and gene sets enrichment analyses. The prognostic role of COL1A1, FN1, EDN1 (ET-1) and ARRB1 (β-arr1) gene expression was evaluated using the Kaplan-Meier plotter database and clinical ovarian cancer tissue samples.

resultsWe demonstrated that ET-1 boosts Col1 and FN expression in HOFs, akin to ovarian CAF levels. Both receptors are implicated, evident from inhibitory effects after ET

conclusionsThese findings hint at ET-1 involvement in ECM remodeling and early SOC stages by modulating the expression of Col1 and FN. Targeting ET-1 signaling with ET

Indexed as

beta-Arrestin 1Collagen Type IEndothelin-1FibroblastsFibronectinsOvarian NeoplasmsAnimalsCancer-Associated FibroblastsCell Line, TumorCollagen Type I, alpha 1 ChainFemaleHumansMiceOvarySignal TransductionARRB1 protein, humanbeta-Arrestin 1COL1A1 protein, humanCollagen Type ICollagen Type I, alpha 1 ChainEndothelin-1FibronectinsFN1 protein, humanEndothelin-1Endothelin receptorsFibroblastsFibronectinOvarian cancerType I collagenβ-arrestin 1

Identifiers

PMID39985042
PMCPMC11844176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.